Tag Archives: Prix Galien

Ethics in Drug Innovation: The First Hurdle is Trust

By Guest Blogger | Published: October 19, 2012
By Ansis Helmanis Ethics is a matter of trust, which in the regulatory space requires transparency and openness among all stakeholders, including patients and industry.  This was the consensus of FDA Commissioner Margaret Hamburg and European Medicines Agency (EMA) Executive Director Guido Rasi, both of whom shared the podium with Nobel Laureate Professor Elie Wiesel [...]
Posted in Europe, Events, FDA, Global, Guest Blog, Market Access, Patient Communication, Regulatory, healthcare, leadership, pricing | Also tagged , , , , , , , | Leave a comment

Prix Galien Winners Embody Innovation

By Jennifer Ringler | Published: October 4, 2011
The winners of the fifth annual Prix Galien USA represent the progress of the entire industry and show us how far we’ve come in advancing the pace of innovation and commercializing new medicines that save lives and improve standard of care. Pharmaceutical Executive served as a lead media partner for the 2011 Prix Galien awards, held [...]
Posted in Events | Also tagged , | Leave a comment

Prix Galien: Pharma R&D and Payers Need to Talk, Yesterday

By Ben Comer | Published: September 28, 2011
R&D departments and payers need to communicate early in the drug development process: If pharma is a day late, then payers are likely to be a dollar short, according to panelists at the Galien Forum on Tuesday.
Posted in FDA, Market Access, R&D, Strategy, leadership, pricing | Also tagged , , , | Leave a comment

Pharma Celebrates its Own

By Andrew Sheivachman | Published: October 7, 2009
At the gala ceremony for the 2009 Prix Galien USA award on October 1, a paradigm shift in drug development took center stage. “The most successful new [cancer] therapies will be based on a precise molecular understanding of disease basis—that’s exactly what we did with Gleevec,” said keynote speaker Brian Druker, director of the Oregon Health [...]
Posted in Events | Also tagged , , , , , , , , , , , , | Leave a comment

Prix Galien Push for Private/Public Collaboration

By Andrew Sheivachman | Published: October 6, 2009
Preceding the presentation of the 2009 Prix Galien USA prizes, last Tuesday, a round table discussion was conducted at the American Museum of Natural History on the subject of how public and private collaboration can increase innovation and contribute to saving lives around the world. The talk included Leonard Bell of Alexion Pharmaceuticals, Barry Bloom [...]
Posted in Events | Also tagged , , , , , , , | Leave a comment